COMMUNIQUÉS West-GlobeNewswire

-
Transparency notification
19/09/2019 - 22:01 -
Monthly information regarding the total number of voting rights and total number of shares of the Company
19/09/2019 - 22:00 -
Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social
19/09/2019 - 22:00 -
Parallax Health Sciences Announces Acquisition of Minority Interest In Global Career Networks
19/09/2019 - 19:18 -
Blood Advances Publishes Cellworks Prospective Genomic Biosimulation Study that Predicts Cancer Therapy Response with 90% Accuracy
19/09/2019 - 18:13 -
Genkyotex Announces First Half 2019 Results
19/09/2019 - 18:00 -
Genkyotex publie ses résultats semestriels 2019
19/09/2019 - 18:00 -
Valneva Confirms Delisting from the Vienna Stock Exchange
19/09/2019 - 17:45 -
Valneva confirme le retrait de ses actions de la Bourse de Vienne
19/09/2019 - 17:45 -
PSIQ Terminates Letter of Intent to Acquire Ecoland
19/09/2019 - 16:21 -
BrainsWay Announces Further Leadership Transition to U.S.
19/09/2019 - 16:10 -
Veterans Affairs Northeast Ohio Healthcare System Receives Spinal Cord Rehabilitation Exoskeleton from SoldierStrong
19/09/2019 - 16:00 -
BriaCell Announces Public Disclosure: Remarkable Responder in Combination Study of Lead Candidate with KEYTRUDA®
19/09/2019 - 16:00 -
MannKind Presents Positive Afrezza® Clinical Data from Type 1 Diabetes Study at 55th Annual Meeting of the EASD
19/09/2019 - 15:00 -
Aptevo Therapeutics Introduces New Adaptir™ Bispecific Antibody Candidate Intended for the Treatment of Solid Tumors
19/09/2019 - 15:00 -
INSTI now available for expanded point-of-care use in Canada
19/09/2019 - 15:00 -
Rafael Pharmaceuticals Announces Expansion into South Korea of Pivotal Phase 3 Trial (ARMADA 2000) of CPI-613® (devimistat) in Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML)
19/09/2019 - 15:00 -
HOOKIPA to Present Data Demonstrating the Potential of its TheraT® Technology at the Upcoming CICON Conference in Paris
19/09/2019 - 14:55 -
Tauriga Sciences Inc. Increases its Products Liability Insurance Coverage to $5,000,000 and Targets Large National Retail Chains to Further Expand the Market Presence of Tauri-Gum
19/09/2019 - 14:54
Pages